Sigyn Therapeutics (SIGY) Receivables - Net (2017 - 2020)

Sigyn Therapeutics has disclosed Receivables - Net across 3 years of filings, most recently posting $756.0 for Q1 2020.

• In Q1 2020, Receivables - Net changed N/A year-over-year to $756.0; the TTM figure through Mar 2020 stood at $756.0 (changed N/A YoY), while the FY2017 annual figure was $9730.0, changed N/A from the prior year.
• Receivables - Net came in at $756.0 for Q1 2020 at Sigyn Therapeutics, down from $1102.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $63002.0 in Q2 2017 to a low of $756.0 in Q1 2020.
• Average Receivables - Net over 3 years is $17899.5, with a median of $13526.0 recorded in 2017.
• The largest YoY upside for Receivables - Net was 8.01% in 2018 against a maximum downside of 95.22% in 2018.
• Over 3 years, Receivables - Net stood at $9730.0 in 2017, then tumbled by 88.67% to $1102.0 in 2018, then slumped by 31.4% to $756.0 in 2020.
• Per Business Quant data, the three most recent Receivables - Net figures were $756.0 in Q1 2020, $1102.0 in Q3 2018, and $3013.0 in Q2 2018.